Gufic Biosciences Ltd reports Q2 FY27 revenue of ₹288.27 crore and net profit of ₹23.47 crore
- Revenue rose 10.5% sequentially and 21.6% year on year; net profit increased 5.2% sequentially and 39.5% year on year.
- EBIT margin was approximately 14.1%; no exceptional items were reported.
- Statutory auditors’ limited review noted no matter indicating material misstatement.
